Rosai-dorfman Disease
📧 Sign up to get email alerts when something new happens for Rosai-dorfman Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET [EARLY_Phase 1]
Early-phase clinical trial evaluating in-human CXCR4 imaging with [68Ga]-Pentixafor-PET in hematologic and solid tumors; the study is curren…
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: Efficacy and Safety of the RD Regimen(Lenalidomide, Dexamethasone) for Rosai-Dorfman Disease [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of the RD regimen (lenalidomide plus dexamethasone) for Rosai-Dorfman disease; the…
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders [Phase 2]
Phase 2 clinical trial update evaluating cobimetinib in refractory Langerhans cell histiocytosis and other histiocytic disorders, currently …
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: Mirdametinib in Histiocytic Disorders [Phase 2]
Phase 2 clinical trial evaluating mirdametinib for histiocytic disorders including Langerhans cell histiocytosis, Juvenile xanthogranuloma, …
-
CLINICAL_TRIALS research · 2025-06-24Clinical Trial Update: International Rare Histiocytic Disorders Registry (IRHDR)
This clinical trial registry update describes the International Rare Histiocytic Disorders Registry (IRHDR) sponsored by The Hospital for Si…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.